Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.91 USD | +0.38% | +4.55% | +329.39% |
May. 06 | Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing | MT |
May. 03 | Wall St set to open sharply higher on soft jobs data | RE |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Lian
FOU | Founder | 58 | 12-09-23 |
Gregory Zante
DFI | Director of Finance/CFO | 53 | 16-01-04 |
Marianne Mancini
COO | Chief Operating Officer | 59 | 15-04-30 |
Michael Morneau
ADM | Chief Administrative Officer | 58 | 14-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Foehr
BRD | Director/Board Member | 51 | 14-04-30 |
J. Singleton
BRD | Director/Board Member | 71 | 14-04-30 |
Charles Rowland
BRD | Director/Board Member | 65 | 17-06-30 |
Lawson Macartney
CHM | Chairman | 66 | 14-04-30 |
Brian Lian
FOU | Founder | 58 | 12-09-23 |
S. Rouan
BRD | Director/Board Member | 61 | 19-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 110,268,210 | 103,648,545 ( 94.00 %) | 0 | 94.00 % |
Company contact information
Viking Therapeutics, Inc.
9920 Pacific Heights Boulevard Suite 350
92121, San Diego
+858 704 4660
http://www.vikingtherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+329.39% | 8.78B | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
-24.02% | 8.37B |
- Stock Market
- Equities
- VKTX Stock
- Company Viking Therapeutics, Inc.